Optimization of biomarkers-based classification scores as progression-free survival predictors: an intuitive graphical representation

by Manciu, Marian, Hosseini, Sorour, Di Desidero, Teresa, Allegrini, Giacomo, Falcone, Alfredo, Bocci, Guido, Kirken, Robert A, Francia, Giulio
Published in Future Sci OA (2018)

Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction

by Bocci, Guido, Di Paolo, Antonello, Barbara, Cecilia, Masi, Gianluca, Fornaro, Lorenzo, Loupakis, Fotios, Allegrini, Giacomo, Falcone, Alfredo, Del Tacca, Mario, Danesi, Romano
Published 2009

Pharmacodynamic biomarkers in metronomic chemotherapy: multiplex cytokine measurements in gastrointestinal cancer patients

by Valenzuela, Paloma, Oaxaca, Derrick, Desidero, Teresa Di, Parra, Karla, Rodriguez, Georgialina, Manciu, Marian, Allegrini, Giacomo, Falcone, Alfredo, Bocci, Guido, Kirken, Robert A., Francia, Giulio
Published in Clin Exp Med (2020)

Genetic interaction of P2X(7) receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients

by Solini, Anna, Simeon, Vittorio, Derosa, Lisa, Orlandi, Paola, Rossi, Chiara, Fontana, Andrea, Galli, Luca, Di Desidero, Teresa, Fioravanti, Anna, Lucchesi, Sara, Coltelli, Luigi, Ginocchi, Laura, Allegrini, Giacomo, Danesi, Romano, Falcone, Alfredo, Bocci, Guido
Published in Oncotarget (2015)

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

by Marmorino, Federica, Salvatore, Lisa, Barbara, Cecilia, Allegrini, Giacomo, Antonuzzo, Lorenzo, Masi, Gianluca, Loupakis, Fotios, Borelli, Beatrice, Chiara, Silvana, Banzi, Maria Chiara, Miraglio, Emanuela, Amoroso, Domenico, Dargenio, Francesco, Bonetti, Andrea, Martignetti, Angelo, Paris, Myriam, Tomcikova, Daniela, Boni, Luca, Falcone, Alfredo, Cremolini, Chiara
Published in Br J Cancer (2017)

Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers

by Allegrini, Giacomo, Di Desidero, Teresa, Barletta, Maria Teresa, Fioravanti, Anna, Orlandi, Paola, Canu, Bastianina, Chericoni, Silvio, Loupakis, Fotios, Di Paolo, Antonello, Masi, Gianluca, Fontana, Andrea, Lucchesi, Sara, Arrighi, Giada, Giusiani, Mario, Ciarlo, Andrea, Brandi, Giovanni, Danesi, Romano, Kerbel, Robert S., Falcone, Alfredo, Bocci, Guido
Published 2012

A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study

by Corino, Valentina D. A., Bologna, Marco, Calareso, Giuseppina, Licitra, Lisa, Ghi, Mariagrazia, Rinaldi, Gaetana, Caponigro, Francesco, Morelli, Franco, Airoldi, Mario, Allegrini, Giacomo, Cassano, Alessandra, Ferrari, Daris, Mirabile, Aurora, Tosoni, Alicia, Galizia, Danilo, Merlano, Marco, Sponghini, Andrea, Moretti, Gabriella, Mainardi, Luca, Bossi, Paolo
Published in Diagnostics (Basel) (2021)

TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group

by Cremolini, Chiara, Marmorino, Federica, Loupakis, Fotios, Masi, Gianluca, Antoniotti, Carlotta, Salvatore, Lisa, Schirripa, Marta, Boni, Luca, Zagonel, Vittorina, Lonardi, Sara, Aprile, Giuseppe, Tamburini, Emiliano, Ricci, Vincenzo, Ronzoni, Monica, Pietrantonio, Filippo, Valsuani, Chiara, Tomasello, Gianluca, Passardi, Alessandro, Allegrini, Giacomo, Di Donato, Samantha, Santini, Daniele, Falcone, Alfredo
Published in BMC Cancer (2017)

Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer: A...

by Cortés, Javier, Diéras, Véronique, Lorenzen, Sylvie, Montemurro, Filippo, Riera-Knorrenschild, Jorge, Thuss-Patience, Peter, Allegrini, Giacomo, De Laurentiis, Michelino, Lohrisch, Caroline, Oravcová, Eva, Perez-Garcia, Jose M., Ricci, Francesco, Sakaeva, Dina, Serpanchy, Rosanne, Šufliarský, Jozef, Vidal, Maria, Irahara, Natsumi, Wohlfarth, Christine, Aout, Mounir, Gelmon, Karen
Published in JAMA Oncol (2020)

DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer

by Cremolini, Chiara, Del Re, Marzia, Antoniotti, Carlotta, Lonardi, Sara, Bergamo, Francesca, Loupakis, Fotios, Borelli, Beatrice, Marmorino, Federica, Citi, Valentina, Cortesi, Enrico, Moretto, Roberto, Ronzoni, Monica, Tomasello, Gianluca, Zaniboni, Alberto, Racca, Patrizia, Buonadonna, Angela, Allegrini, Giacomo, Ricci, Vincenzo, Di Donato, Samantha, Zagonel, Vittorina, Boni, Luca, Falcone, Alfredo, Danesi, Romano
Published in Oncotarget (2017)